We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $8.17B
1-Year Est. Return 68.82%
This Fund
S&P 500
This Quarter Est. Return
+1.37%
1 Year Est. Return
+68.82%
3 Year Est. Return
+79.68%
5 Year Est. Return
+64.24%
10 Year Est. Return
+259.8%
AUM
$5.76B
AUM Growth
+$32.7M
Cap. Flow
+$188M
Cap. Flow %
3.27%
Top 10 Hldgs %
50.49%
Holding
248
New
70
Increased
46
Reduced
39
Closed
50

Top Buys

Rank Stock Value
1
GSK icon
GSK
GSK
+$136M
2
FRPT icon
Freshpet
FRPT
+$91.3M
3
ROST icon
Ross Stores
ROST
+$81.3M
4
FIVE icon
Five Below
FIVE
+$72.6M
5
EXAS
Exact Sciences
EXAS
+$64.3M

Top Sells

Rank Stock Value
1
DG icon
Dollar General
DG
+$75.6M
2
CPRX
Catalyst Pharmaceutical
CPRX
+$71.5M
3
ILMN icon
Illumina
ILMN
+$62.5M
4
AZN icon
AstraZeneca
AZN
+$55.2M
5
TSCO icon
Tractor Supply
TSCO
+$51.8M

Sector Composition

Rank Sector Weight
1 Healthcare 43.48%
2 Miscellaneous 31.17%
3 Consumer Discretionary 9.47%
4 Consumer Staples 8.21%
5 Technology 4.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KHC icon
26
Kraft Heinz
KHC
$29.7B
$55M 0.95%
1,650,000
+126,000
+8% +$4.68M
AGIO icon
27
Agios Pharmaceuticals
AGIO
$2.02B
$54.4M 0.94%
+1,924,000
New +$51.6M
CENTA icon
28
Central Garden & Pet Co Class A
CENTA
$2.21B
$52.9M 0.92%
1,937,500
-92,500
-5% -$2.9M
BUD icon
29
AB InBev
BUD
$157B
$51.8M 0.9%
1,148,000
+12,000
+1% +$622K
EXAS
30
DELISTED
Exact Sciences
EXAS
$50.7M 0.88%
+1,560,000
New +$64.3M
ADBE icon
31
Adobe
ADBE
$102B
$50.6M 0.88%
184,000
+64,000
+53% +$24.2M
GOOGL icon
32
Alphabet (Google) Class A
GOOGL
$4.13T
$44.8M 0.78%
468,000
+328,000
+234% +$36.4M
TGT icon
33
Target
TGT
$73.8B
$44.7M 0.77%
+300,989
New +$48.2M
VRTX icon
34
Vertex Pharmaceuticals
VRTX
$134B
$43.4M 0.75%
150,000
-162,000
-52% -$46.6M
ISRG icon
35
Intuitive Surgical
ISRG
$124B
$42.7M 0.74%
228,000
+80,000
+54% +$17.2M
BMY icon
36
Bristol-Myers Squibb
BMY
$132B
$42.7M 0.74%
600,000
-556,000
-48% -$40.3M
ARGX icon
37
argenx
ARGX
$63.2B
$42.4M 0.73%
120,000
-68,000
-36% -$25.2M
DECK icon
38
Deckers Outdoor
DECK
$11.2B
$39.6M 0.69%
+760,668
New +$39.6M
OGN icon
39
Organon & Co
OGN
$3.62B
$39.6M 0.69%
+1,692,000
New +$51.1M
ENR icon
40
Energizer
ENR
$1.45B
$39M 0.68%
1,552,000
+788,000
+103% +$23M
MSFT icon
41
Microsoft
MSFT
$3.66T
$37.5M 0.65%
161,000
+25,000
+18% +$6.6M
ZYME icon
42
Zymeworks
ZYME
$2.03B
$35.6M 0.62%
5,785,000
+13,000
+0.2% +$78.4K
FL
43
DELISTED
Foot Locker
FL
$32.4M 0.56%
1,041,769
+592,349
+132% +$18.9M
MDLZ icon
44
Mondelez International
MDLZ
$78.8B
$31.3M 0.54%
571,000
-185,000
-24% -$11.5M
PARA
45
DELISTED
Paramount Global Class B
PARA
$30.5M 0.53%
1,600,000
+764,000
+91% +$18.3M
NTRA icon
46
Natera
NTRA
$46.8B
$29.4M 0.51%
672,000
– –
AMZN icon
47
Amazon
AMZN
$2.77T
$26.8M 0.47%
237,500
+29,402
+14% +$3.72M
POST icon
48
Post Holdings
POST
$3.79B
$26.5M 0.46%
324,000
-212,000
-40% -$18.3M
BABA icon
49
Alibaba
BABA
$280B
$25.9M 0.45%
324,000
+74,000
+30% +$7.05M
TMO icon
50
Thermo Fisher Scientific
TMO
$224B
$25.4M 0.44%
50,000
-14,000
-22% -$7.83M
1
2
3 4 5

Similar funds

MWM
Mission Wealth Management Santa Barbara, California $8.18B AUM 28.28% 1-Year Est. Return
BP
Ballentine Partners Waltham, Massachusetts $8.18B AUM 27.59% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return
SC
Saturna Capital Bellingham, Washington $8.19B AUM 42.01% 1-Year Est. Return
SFM
Soros Fund Management New York $8.14B AUM 35.85% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return
BIM
Bridges Investment Management Omaha, Nebraska $8.22B AUM 21.38% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return

Armistice Capital's Q3 2022 Portfolio in Review

As of Q3 2022, Armistice Capital held 248 positions worth $5.76B, up 0.57% from $5.73B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Armistice Capital deployed $188M of net new capital in Q3 2022, opening 70 new positions and adding to 46 existing holdings. Its largest new stake was GSK: 3,600,000 shares worth $106M.

By sector, the portfolio is most concentrated in Healthcare at 43% of assets, down from 44% a quarter earlier, followed by Miscellaneous and Consumer Discretionary.

On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $46.6M trimmed.

  • Armistice Capital's largest Q3 2022 buy was GSK: 3,600,000 shares worth $106M.
  • Armistice Capital added most to Freshpet in Q3 2022, an estimated $91.3M increase.
  • Armistice Capital's biggest Q3 2022 reduction was Vertex Pharmaceuticals, cutting an estimated $46.6M.
  • Armistice Capital fully exited Dollar General in Q3 2022, selling an estimated $75.6M.
  • Armistice Capital's ten largest holdings make up 50% of its $5.76B portfolio in Q3 2022.
  • Armistice Capital opened 70 new positions and closed 50 in Q3 2022.
  • Armistice Capital's portfolio value rose 0.57% quarter-over-quarter to $5.76B.

Based on Armistice Capital's 13F filing for Q3 2022, filed 14 Nov 2022.